Literature DB >> 1911109

Further evidence of lipid peroxidation in post-enteropathic haemolytic-uraemic syndrome.

R D Situnayake1, B J Crump, D I Thurnham, C M Taylor.   

Abstract

Lipid peroxidation may play a role in the pathogenesis of the haemolytic-uraemic syndrome (HUS). Thirteen children with the post-enteropathic form of HUS were studied using conjugated diene lipids as markers of in vivo lipid peroxidation. Levels of total conjugated diene lipids and 9,11-linoleic acid, the principal conjugated diene in human plasma, were greater in the acute phase of this disorder than in controls. The ratio of plasma vitamin E to lipid was lower than that in children with other renal diseases, and the expected positive correlation between vitamin E and lipids did not hold for HUS patients. These data provide further evidence of lipid peroxidation in HUS and a disturbance in the metabolism of the principal lipid-bound anti-oxidant vitamin E.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911109     DOI: 10.1007/bf01453659

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Neutrophil elastases and haemolytic uraemic syndrome.

Authors:  D Milford; C M Taylor; F Rafaat; E Halloran; J Dawes
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Etiology and pathogenesis of the hemolytic-uremic syndrome. A hypothesis.

Authors:  M Wolman
Journal:  Isr J Med Sci       Date:  1972-07

4.  A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios.

Authors:  G W Burton; A Webb; K U Ingold
Journal:  Lipids       Date:  1985-01       Impact factor: 1.880

5.  Haemolytic uraemic syndrome.

Authors:  M Levin; J M Barratt
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

6.  Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome.

Authors:  K D Forsyth; A C Simpson; M M Fitzpatrick; T M Barratt; R J Levinsky
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

7.  Identification of a diene conjugated component of human lipid as octadeca-9,11-dienoic acid.

Authors:  S A Iversen; P Cawood; M J Madigan; A M Lawson; T L Dormandy
Journal:  FEBS Lett       Date:  1984-06-11       Impact factor: 4.124

8.  Changes in the postenteropathic form of the hemolytic uremic syndrome in children.

Authors:  N A Coad; T Marshall; B Rowe; C M Taylor
Journal:  Clin Nephrol       Date:  1991-01       Impact factor: 0.975

9.  Vitamin E treatment of haemolytic uraemic syndrome.

Authors:  H R Powell; D A McCredie; C M Taylor; J R Burke; R G Walker
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

10.  Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis.

Authors:  J Lunec; S P Halloran; A G White; T L Dormandy
Journal:  J Rheumatol       Date:  1981 Mar-Apr       Impact factor: 4.666

View more
  2 in total

Review 1.  Haemolytic uraemic syndrome.

Authors:  W L Robson
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

2.  Oxidative damage of red blood cells in haemolytic uraemic syndrome.

Authors:  S Túri; I Németh; I Vargha; B Matkovics
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.